Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Kamada (NASDAQ:KMDA) through any online brokerage.
Other companies in Kamada’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Kamada has a consensus price target of $14.25.
The stock price for Kamada (NASDAQ: KMDA) is $8.33 last updated October 1, 2026 at 8:29 AM EDT.
There are no upcoming dividends for Kamada.
Kamada does not have any upcoming earnings scheduled.
There is no upcoming split for Kamada.
Kamada is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.